Oral candidiasis: relation to systemic diseases and medications

Xiaozhu Chu

Abstract


Background: Oral candidiasis is by far the most common oral fungal infection in humans. It is caused by the fungal organism Candida albicans. When the host is debilitated by other diseases and conditions, C. albicans, which is usually a part of the normal oral flora, can turn pathogenic and invade the host tissue to cause the infection. The purpose of this paper is to investigate the role of systemic diseases and medications in the development of oral candidiasis.

Methods: A total of 12 cases with code indicating oral candidiasis were collected from the University of Pittsburgh School of Dental Medicine Dental Registry and DNA Repository. The systemic diseases and medications were descriptively analyzed.

Results: 50% of the subjects had more than two systemic diseases. The most prevalent diseases were mental illnesses (50%), cardiovascular diseases (41.7%), and respiratory system diseases (33.3%). 50% of subjects were on polypharmacy therapies and 75% of subjects were taking medications that may contribute to oral candidiasis. Among the medications, antidepressants and inhalational corticosteroids may have strong potentials to cause oral candidiasis.

Conclusion: Oral candidiasis is associated with having systemic diseases and intake of medication, especially with those medications can cause xerostomia. As the number of systemic diseases and medications increases, the risk of developing oral candidiasis may increase too.


Keywords


oral candidiasis; disease; medication; xerostomia

Full Text:

PDF

References


Neville B, Damm D, Allen C, Bouquot J. (2009) Oral and Maxillofacial Pathology. 3rd ed. St. Louis: Saunders, an imprint of Elsevier. 213-224 p.

Elucidating the role of hyposalivation and autoimmunity in oral candidiasis. Billings M, Dye BA, Iafolla T, Grisius M, Alevizos I. Oral Dis. 2017 Apr;23(3):387-394. doi: 10.1111/odi.12626. Epub 2017 Feb 8. PMID: 27998016

Chronic mucocutaneous candidiasis disease associated with inborn errors of IL-17 immunity. Okada S, Puel A, Casanova JL, Kobayashi M. Clin Transl Immunology. 2016 Dec 2;5(12):e114. doi: 10.1038/cti.2016.71. eCollection 2016 Dec. Review. PMID: 28090315

The impact of cigarette/tobacco smoking on oral candidosis: an overview. Soysa NS, Ellepola AN. Oral Dis. 2005 Sep;11(5):268-73. Review. PMID: 16120112

Saliva-microbe interactions and salivary gland dysfunction. Baker OJ, Edgerton M, Kramer JM, Ruhl S. Adv Dent Res. 2014 May;26(1):7-14. doi: 10.1177/0022034514526239. Review. PMID: 24736699

Epidemiology and etiology of denture stomatitis. Gendreau L, Loewy ZG. J Prosthodont. 2011 Jun;20(4):251-60. doi: 10.1111/j.1532-849X.2011.00698.x. Epub 2011 Apr 4. Review. PMID: 21463383

Candidal overgrowth in diabetic patients: potential predisposing factors. Belazi M, Velegraki A, Fleva A, Gidarakou I, Papanaum L, Baka D, Daniilidou N, Karamitsos D. Mycoses. 2005 May;48(3):192-6. PMID: 15842336

Fungal infections of the oral mucosa. Krishnan PA. Indian J Dent Res. 2012 Sep-Oct;23(5):650-9. doi: 10.4103/0970-9290.107384. Review. PMID: 23422613

Risks for oral health with the use of antidepressants. Peeters FP, deVries MW, Vissink A. Gen Hosp Psychiatry. 1998 May;20(3):150-4. Review. PMID: 9650032

Inhalational and topical steroids, and oral candidosis: a mini review. Ellepola AN, Samaranayake LP. Oral Dis. 2001 Jul;7(4):211-6. Review. PMID: 11575870




DOI: https://doi.org/10.5195/d3000.2017.74

Refbacks

  • There are currently no refbacks.